DNA Biomed Solns (DNA) — Free Cash Flow Generation Index
Latest as of December 2022:
1.00x
DNA Biomed Solns (DNA) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of ILA394.50K represents 1% of operating cash flow (ILA394.50K). Read total liabilities of DNA Biomed Solns for a breakdown of total debt and financial obligations.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
ILA394.50K
ILA
Operating Cash Flow
ILA394.50K
ILA
Capital Expenditures
ILA0.00
ILA
DNA Biomed Solns Free Cash Flow Generation Index (2024–2024)
Historical FCF Generation Index trend for DNA Biomed Solns across 1 annual periods.
Annual Free Cash Flow Generation for DNA Biomed Solns (2024–2024)
Year-by-year Free Cash Flow Generation Index for DNA Biomed Solns. For the full company profile including market capitalisation, see DNA company net worth.
| Year | FCG Index | Free Cash Flow (ILA) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.00x | ILA1.61 Million | ILA1.61 Million | ILA0.00 | — |
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).